Baker Bros. Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Baker Bros. Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-387,741	Closed	-$29.2M	–	138
2015 Q2	$29.2M	Buy	387,741 +33,476	+9%	+$1.79M	0.26%	39
2015 Q1	$17.8M	Buy	354,265 +68,010	+24%	+$2.85M	0.15%	44
2014 Q4	$9.93M	Sell	286,255 -25,000	-8%	-$872K	0.1%	48
2014 Q3	$10.2M	Hold	311,255	–	–	0.13%	45
2014 Q2	$11.9M	Hold	311,255	–	–	0.15%	44
2014 Q1	$12.4M	Sell	311,255 -1,936	-0.6%	-$86.6K	0.16%	44
2013 Q4	$11.7M	Buy	313,191 +48,191	+18%	+$2M	0.16%	44
2013 Q3	$12.1M	Buy	265,000 +100,000	+61%	+$2.99M	0.17%	38
2013 Q2	$4.46M	Buy	+165,000	New	+$3.78M	0.09%	50

Other funds holding KYTH

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Baker Bros. Advisors's KYTH Position: Q3 2015 in Review

Baker Bros. Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015, closing a stake of 387,741 shares — an estimated $29.2M sold.

Baker Bros. Advisors first reported a position in KYTH in Q2 2013 and held it in 9 quarters. The position peaked at $29.2M in Q2 2015. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

Baker Bros. Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2015 after selling out during the quarter.
Baker Bros. Advisors sold 387,741 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2015, an estimated $29.2M.
Baker Bros. Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 9 quarters.
Baker Bros. Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $29.2M in Q2 2015.
143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on Baker Bros. Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.